Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Margin of Safety % (DCF FCF Based): N/A (As of Aug. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SUNPHARMA Sun Pharmaceuticals Industries Ltd NSE:SUNPHARMA
92 GF Score
Price ₹1,902.40
GF Value ₹1,954.01
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Sun Pharmaceuticals Industries Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Sun Pharmaceuticals Industries's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

NSE:SUNPHARMA vs ZTS, UTHR: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharmaceuticals Industries's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sun Pharmaceuticals Industries Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sun Pharmaceuticals Industries's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Sun Pharmaceuticals Industries's Margin of Safety % (DCF FCF Based) falls into.


NSE:SUNPHARMA
92GF Score
Sun Pharmaceuticals Industries Ltd NSE:SUNPHARMA
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Overvalued in 2026?

Based on GuruFocus' analysis, Sun Pharmaceuticals Industries stock appears to be undervalued. The current stock price of ₹1,902.40 is trading 2.6% below its estimated GF Value™ of ₹1,954.01. GuruFocus considers Sun Pharmaceuticals Industries to be Fairly Valued.

Key valuation signals for NSE:SUNPHARMA:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: ₹1,954.01 vs. price of ₹1,902.40 (2.6% below fair value)
  • GF Score™: 92/100 with 2 warning signs

No single metric tells the full story. See the NSE:SUNPHARMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sun Pharmaceuticals Industries Business Description

Other Exchanges 524715:India
Address Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063
Sun Pharmaceuticals Industries Ltd is India's generic pharmaceutical manufacturing company. The company's substantial markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is majorly based in India.
92GF Score

Get the complete analysis for NSE:SUNPHARMA

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,902.40
Price
₹1,954.01
GF Value